Pallas Capital Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Buy
30,721
+1,506
+5% +$73.3K 0.05% 245
2026
Q1
$1.25M Sell
29,215
-19,049
-39% -$819K 0.05% 283
2025
Q4
$2.12M Buy
48,264
+14,405
+43% +$596K 0.07% 208
2025
Q3
$1.4M Sell
33,859
-10,957
-24% -$440K 0.05% 268
2025
Q2
$1.98M Sell
44,816
-2,833
-6% -$113K 0.08% 199
2025
Q1
$1.76M Buy
47,649
+25,322
+113% +$902K 0.07% 200
2024
Q4
$743K Buy
22,327
+13,572
+155% +$440K 0.03% 297
2024
Q3
$246K Buy
+8,755
New +$218K 0.01% 520

Other funds holding EXEL

Pallas Capital Advisors's EXEL Position: Q2 2026 in Review

Pallas Capital Advisors increased its Exelixis (EXEL) stake by 5.2% in Q2 2026, buying an estimated $73.3K and bringing the position to 30,721 shares worth $1.67M. The position accounts for 0.05% of the portfolio, ranked #245.

Pallas Capital Advisors first reported a position in EXEL in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.12M in Q4 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Pallas Capital Advisors held 30,721 shares of Exelixis worth $1.67M as of Q2 2026.
  • Pallas Capital Advisors bought 1,506 Exelixis shares in Q2 2026, an estimated $73.3K.
  • Exelixis made up 0.05% of Pallas Capital Advisors's portfolio in Q2 2026, its #245 holding.
  • Pallas Capital Advisors first reported a position in Exelixis in Q3 2024 and has held it in 8 quarters since.
  • Pallas Capital Advisors's Exelixis position peaked at $2.12M in Q4 2025.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.